Transform Clinical Outcomes & Patient Experience1
SOMAVAC® delivers deep tissue negative pressure therapy: continuous sensor-controlled suction at −100mmHg directly into the wound space. A better surgical recovery experience for your patients.1
Reduce risk of complications. Faster drain removal. Patients who love the experience.1 24/7 support so your staff isn’t fielding drain calls.
In Use at Leading Institutions
Deep Tissue Negative Pressure Therapy
The Problem: Seroma
Fluid accumulates in the dead space, preventing tissue healing
The Solution: Deep Tissue Negative Pressure Therapy
Continuous −100mmHg removes fluid and promotes tissue apposition1
If You Like Surface Negative Pressure Wound Therapy, You’ll Love This
Already using Prevena or similar surface negative pressure wound therapy? SOMAVAC® is the natural complement, same proven negative pressure technology, applied where it’s never been before: directly into the deep wound space.
Surface Negative Pressure Wound Therapy
Traditional Surface Devices
- Pressure on incision surface
- Helps surface tissues approximate for incision healing
- Does not remove fluid from deep wound space
- Does not create deep tissue apposition or promote ADM integration
SOMAVAC® Deep Tissue Therapy1
First & Only
- Continuous −100mmHg into the deep wound space
- Removes fluid to prevent seroma formation
- Creates tissue apposition for proper healing
- Reduces infection risk by eliminating waste fluid
How SOMAVAC® Works
As flat as a phone, worn discreetly on a belt under clothing. Connects up to 4 surgical drains.
Elevate Your Standard of Care
SOMAVAC® Deep Tissue Therapy delivers measurable improvements across the metrics that matter most to your practice.1
Faster Drain Removal1
Continuous −100mmHg deep tissue suction removes fluid faster than passive bulbs. 11.4 days on average, as early as 8.3 days, up to 30% sooner.*
Reduced Risk of Complications1
Fully closed system minimizes surgical site exposure. In the Walker study, SOMAVAC® patients had a 0% seroma rate (vs. 13.6%, p=.009). Timely removal reduces infection risk, which triples after 3 weeks3.
24/7 Patient Support
Fewer drain-related calls to your staff. Our U.S.-based team answers the phone 24/7 (real people, no robots) so your patients get help without burdening your office.
Reduced Reoperations
1 in 5 women require reoperation with traditional drains4. In the Walker study, SOMAVAC® delivered an 86% reduction in reoperations (2% return to OR vs. 13.6%, p=.05)5.
Higher Patient Satisfaction
Patients rated SOMAVAC® easier to use than a thermometer. SUS score: 93.1 (“best imaginable”) vs. 46.7 for JP bulbs.*1,6
Fewer Follow-Up Visits
Faster drain removal and fewer complications reduce post-operative office visits, freeing clinical time and improving throughput.1
Your Patients Hate Drains More Than You Think
A 2025 peer-reviewed study of 203 patients reveals just how much surgical drains impact quality of life.7 Most surgeons know patients dislike drains, but they don’t realize how much until they see the data.
Patients in communities where SOMAVAC® is available have started requesting it by name, and some are choosing their surgeon based on who offers it. This isn’t just a clinical upgrade. It’s a practice differentiator.
“I’m kind of embarrassed to admit this, but I didn’t realize how much my patients disliked the drains. After my first case with SOMAVAC, and hearing how grateful my patients were to not deal with the bulbs, it completely changed my perspective on the recovery experience.”
Board-certified plastic surgeon, after first use
Patient Attitudes on Surgical Drains7
N = 203 • Gadiraju et al. Plastic and Reconstructive Surgery, Global Open, 2025
Drains were a significant aspect of my recovery
90%
62.1% strongly agree • 28.1% agree
Drains made it harder to complete daily tasks
85%
47.3% strongly agree • 37.4% agree
Drains negatively impacted my quality of sleep
77%
44.8% strongly agree • 32.0% agree
Drains negatively impacted my mood
66%
35.5% strongly agree • 30.5% agree
Knowing I’d need a drain would make me apprehensive about future surgery
37%
16.3% strongly agree • 20.7% agree
I would prefer surgeons who use improved alternatives to existing drains
65%
34.0% strongly agree • 31.0% agree
Data That Speaks for Itself
30%
Drains Out Sooner1
11.4 days on average, as early as 8.3 days, vs. 16.3 days with JP bulbs. SOMAVAC group (n=45), p=0.003.
86%
Reduction in Reoperations1
86% reduction in return to the OR: 2% vs. 14% with JP bulbs in the Walker study (p=.05, n=49).5
9.27
Patient Satisfaction1
Mean satisfaction on the Likert scale in the Walker study (p=0.008, n=49).
Average Time With Drains1
Prospective mastectomy study • N=45 • p=0.003 • Data on file
11.4 days
SOMAVAC®
16.3 days
JP Bulbs
Nearly 5 fewer days with drains
Ease of Use (SUS Score)1,6
Patient-reported • 0 to 100 scale • p=0.0008 • Data on file
46.7
JP Bulbs
93.2
SOMAVAC
82
Thermometer
78
Inhaler
Rated “best imaginable” on SUS scale. Thermometer & Inhaler: Kortum & Peres (2015). Data on file.
*Early clinical results. Data on file. References: Walker et al. (in review); Hanna et al. (2016); Kortum & Peres (2015).
JP Bulbs Do Not Provide Continuous Suction1,8
Ability of drain to collect fluid: 100-mL bulb
JP bulb suction drops to <40mmHg within 30mL of fluid collection. SOMAVAC® maintains a continuous −100mmHg.
*Carruthers et al. 2013. Optimizing the Closed Suction Surgical Drainage System. American Society Plastic Surgical Nursing.
Drains Out Sooner With SOMAVAC®1
More fluid out up front means patients enter the remodeling stage sooner, so drains can come out at your discretion, days earlier.
Representative Drain Output1
*Data on file
Study at a Glance
30% Faster Drain Removal1
Continuous suction vs. passive bulb drainage
Simplifies Post-Operative Experience1
Efficient deep tissue fluid removal via one device
Easier Than a Thermometer1,6
Patient-reported System Usability Scale scores
Continuous Sensor-Controlled Suction1
Maintains −100mmHg, no manual compression needed
Fully Closed System
One-way connectors minimize surgical site exposure
150-Patient Study1
Presented at SESPRS and in review: 0% seroma (p=.009), 86% reduction in reoperations (p=.05), 9.27 satisfaction (p=.008), n=49
FDA-Cleared for Seroma Prophylaxis
SOMAVAC® is indicated for removal of bodily fluids following large flap forming plastic and general surgeries. Most commonly used in:
Mastectomy
Reconstruction
Hernia Repair
Abdominoplasty
Paniculectomy
What Surgeons Are Saying
“Since using SOMAVAC in my breast and abdomen cases, I have not taken a single patient back to the Operating Room for seroma or revision surgery due to a postoperative complication.”
Marc E. Walker, MD, MBA
Plastic & Hand Surgery, UMMC, Jackson
“SOMAVAC feels like a true step forward! What was once an uncomfortable part of recovery is now streamlined, clean and far easier for the patient and surgical team!”
Regina Fearmonti, MD
Plastic & Reconstructive Surgery, Alon Aesthetics, San Antonio
“SOMAVAC is an exciting new technology designed to enhance patient recovery and improve overall outcomes. Early feedback indicates significant improvements in patient comfort and satisfaction.”
Aldona Spiegel, MD
Director, Center for Breast Restoration, Houston Methodist Hospital
The Case for Your VAC Committee
Seroma complications drive costly reoperations and readmissions. SOMAVAC® Deep Tissue Therapy addresses the root cause, delivering measurable savings.
$204K
Savings per 100 surgeries
$10.7K
Mean cost per SSI (Olsen et al.)9
86%
Reduction in reoperations: 2% vs. 14% with bulbs (Walker)1
Economic model based on published literature and clinical data. Reoperation costs estimated at $25K to $46K per event. SSI data from Olsen et al. (2008). Covered within the overall cost of surgery.
Clinician FAQ
Bring SOMAVAC® to Your Practice
Our clinical team handles onboarding, training, and ongoing support to integrate SOMAVAC® into your workflow.
Clinical consultation & product demo
Our team walks through the device, data, and integration process
VAC committee support
We support you through the VAC approval process
Full clinical data package
Early results, SUS scores, peer-reviewed references
Staff training & patient education materials
24/7 U.S.-based patient support included: (833) 766-2822